Talecris to announce expansion, shares company results

Talecris Biotherapeutics on Friday is expected to announce a plan to expand its plant in North Carolina. The first phase of the expansion is anticipated to be a $280 million facility for the separation of blood plasma proteins used in drug development. The company also reported an increase in revenue and profit during the third quarter, owing to sales of its blood plasma-derived drug products.

View Full Article in:

News & Observer (Raleigh, N.C.), The · News & Observer (Raleigh, N.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA